Anti-B7-H4 antibodies and immunoconjugates

Flag tagged CD19-CAR-T cells

Anti-CD30 chimeric antigen receptors

VEGF/DLL4 BINDING AGENTS AND USES THEREOF

Antibody facilitating programmed necrosis of cells and application thereof

Carbohydrate content of CTLA4 molecules

Composition for overcoming resistance to EGFR-targeting agent

Antigen binding proteins that bind PD-L1

BETA-GLUCAN IN COMBINATION WITH ANTI-CANCER AGENTS AFFECTING THE TUMOR MICROENVIRONMENT

Methods for determining the likelihood of survival and for predicting likelihood of metastasis in cancer patients

ANTIBODIES AGAINST G-CSFR AND USES THEREOF

Binding members to PD-L1

Agents for treatment of claudin expressing cancer diseases

Antibody targeting cell surface deposited complement protein C3d and use thereof

ENGINEERED HIGH-AFFINITY HUMAN T CELL RECEPTORS

Compounds and methods for the treatment of TROP2 positive diseases

REDIRECTING IMMUNE RESPONSES

Bispecific coupled antibody, preparation method and application thereof

ANTI-CD37 CHIMERIC ANTIGEN RECEPTORS AND IMMUNE CELLS EXPRESSING THEM

Antibody against glypican-3 and application thereof

DLL3 MODULATORS AND METHODS OF USE

Cadherin-17 specific antibodies and cytotoxic cells for cancer treatment

BCMA monoclonal antibody-drug conjugate

Immunoconjugate and uses thereof

POLYPEPTIDES, ANTIBODY VARIABLE DOMAINS & ANTAGONISTS

Frizzled5 protein-binding agents

Binding molecules specific for HER3 and uses thereof

Antibodies for the treatment of cancers

Use of trans-[tetrachlorobis(1H-indazole)ruthenate(III)] for the treatment of cancer

T CELL ACTIVATING BISPECIFIC ANTIGEN BINDING MOLECULES

Bispecific antibody or antibody mixture with common light chains

Method of treating an NME7 expressing cancer with a peptide

ANTI-NME ANTIBODY

Human monoclonal antibodies that bind CXCR4 and uses thereof

Antibody against EGFRvIII and use thereof

ROR2 antibody compositions and related methods

Generating multispecific antibody mixtures and methods of uses thereof

Formulation for antibody and drug conjugate thereof

Therapeutic and diagnostic methods for autism spectrum disorders and other conditions

Cancer

Targeting o-acetylated gd2 ganglioside as a new therapeutic and diagnostic strategy for cancer

Therapeutic anti-CD9 antibody

Biological materials related to HER3

Immunomodulation by anti-CD3 immunotoxins to treat cancers bearing or not uniformly bearing surface CD3

Humanized, mouse or chimeric anti-CD47 monoclonal antibodies

ANTIBODIES THAT BIND HUMAN PROTEIN TYROSINE PHOSPHATASE beta (HPTPbeta) AND USES THEREOF

Bi-specific antibodies and uses thereof

NOVEL SEZ6 MODULATORS AND METHODS OF USE

Antibody/T-cell receptor chimeric constructs and uses thereof

PSMA binding antibody and uses thereof

Uses of indolinone compounds

Anti-CD3 antibodies and methods of use

Activatable anti-PDL1 antibodies, and methods of use thereof

ANTI-PD-L1 ANTIBODIES, COMPOSITIONS AND ARTICLES OF MANUFACTURE

Antibody constructs for CDH19 and CD3

ANTI-NEUROTENSIN ANTIBODIES AND USES THEREOF

Antibodies to surface determinants

T cell receptors recognizing HLA-A1- or HLA-CW7-restricted mage

ADHERENT CANCER CELL LINE EXPRESSING A HEMATOLOGICAL TUMOR ANTIGEN

Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity

Compositions and methods for detecting and treating esophageal cancer

ANTIBODY THERAPEUTICS THAT BIND PSMA

Anti-cancer fusion polypeptide

Therapeutic antibodies and uses thereof

Antibodies for treatment of cancer expressing claudin 6

Multispecific polypeptide constructs having constrained CD3 binding and methods of using the same

Humanized anti-human epidermal growth factor receptor antibody and application thereof

Anti-BAG3 antibodies for therapeutic use

Checkpoint inhibitor and a whole cell mycobacterium for use in cancer therapy

Compositions and methods for detecting and treating ovarian cancer

BISPECIFIC FC MOLECULES

Modified J-chain

Bispecific T cell activating antigen binding molecules

Bispecific T cell activating antigen binding molecules

CD33 SPECIFIC CHIMERIC ANTIGEN RECEPTORS FOR CANCER IMMUNOTHERAPY

Anti-CD33 antibodies and methods of use thereof

Antibodies specific for Trop-2 and their uses

Treatment of fibrosis with interleukin-11 antibody

Anti-GM-CSF antibodies and uses thereof

Monoclonal antibodies for use in diagnosis and therapy of cancers and autoimmune disease

Deimmunized Serum-Binding Domains and Their Use in Extending Serum Half-Life

ANTIBODIES AGAINST IMMUNOGENIC GLYCOPEPTIDES, COMPOSITIONS COMPRISING THE SAME AND USE THEREOF

Anti-Jagged1 antibodies and methods of use

Caninized human antibodies to human IL-4R alpha

Anti-Axl antibodies

Gene signatures for determining ICOS expression

Multispecific antibodies that target HIV GP120 and CD3

Treatment of fibrosis with interleukin-11 receptor alpha antibody

Treatment of fibrosis with interleukin-11 receptor alpha antibody

COMBINATION THERAPY OF CANCER WITH ANTI-ENDOGLIN ANTIBODIES AND ANTI-VEGF AGENTS

Therapeutic DLL4 Binding Proteins

Multi-specific binding conjugate, related pharmaceutical compositions and use

Virus encoding an anti-TCR-complex antibody or fragment

Certain Improved Human Bispecific EGFRvIII Antibody Engaging Molecules

ESOPHAGEAL CANCER MARKER AND USE THEREOF

ANTI-BLOOD DENDRITIC CELL ANTIGEN 2 ANTIBODIES AND USES THEREOF

Means and methods for treating HBV infection and associated conditions

Treatment of fibrosis with interleukin-11 antibody

Treatment of fibrosis with interleukin-11 receptor alpha antibody

Treatment of fibrosis with IL-11 receptor alpha antibody

Treatment of fibrosis with Interleukin-11 receptor alpha antibody

Treatment of fibrosis with interleukin-11 receptor alpha antibody

Treatment of fibrosis with interleukin-11 antibody

Treatment of fibrosis with interleukin-11 antibody

Treatment of fibrosis with interleukin-11 antibody

Treatment of fibrosis with interleukin-11 antibody

Anti-GM-CSF antibodies and uses thereof

ANTI-NGF ANTIBODIES AND THEIR USE

csPCNA Isoform Antibodies And Uses Thereof

ANTIBODY-DRUG CONJUGATE HAVING IMPROVED STABILITY AND USE THEREOF

Chimeric antigen receptors targeting B-cell maturation antigen and uses thereof

Production of T cell retargeting hetero-dimeric immunoglobulins

Method employing bispecific protein complex

Antibodies that specifically bind PD-1 and methods of use

Compositions and methods for diagnosis and treatment of hepatic cancers

Compositions and methods for treating cancer with anti-CD19/CD20 immunotherapy

Polypeptides inhibiting CD40L

Methods of use of anti-CD123 antibodies and antigen-binding fragments thereof

Antibodies which specifically bind fibroblast growth factor receptor 1, encoding nucleic acids thereof, and methods of producing thereof

Anti-TIGIT antibodies and methods of use thereof

Methods of reducing liver PD-1-expressing CD8+ T cells using PD-1 Fc fusion proteins that bind Fc receptors

Anti-human ADRB3 monoclonal antibody and application thereof in disease diagnosis and treatment

Antibodies and molecules that immunospecifically bind to BTN1A1 and the therapeutic uses thereof

Therapeutic antibodies against ROR-1 protein and methods for use of same

Antibodies specific for FLT3 and their uses

Human monoclonal antibodies to ganglioside GD2

ANTI-OX40 ANTIBODIES AND THEIR USES

ANTIGEN-BINDING MOLECULE AND USES THEREOF

Human monoclonal anti-PD-L1 antibodies and methods of use

Antibodies against human CSF-1R and uses thereof

Antibody To Be Cross-Linked To Human SEMA3A And Use Thereof

SITE-SPECIFIC ANTIBODY CONJUGATION METHODS AND COMPOSITIONS

Compositions and methods for making antibody conjugates

HUMANIZED PAN-HER ANTIBODY COMPOSITIONS

Peptides and combination of peptides and scaffolds for use in immunotherapy against Renal Cell Carcinoma (RCC) and other cancers

Antagonistic anti-CD40 antibodies and methods of antagonizing CD40 activity

ROR1 antibody compositions and related methods

Targeted immunotolerance

BTLA agonist antibodies and uses thereof

Fusion polypeptides which bind vascular endothelial growth factor a (VEGF-A) and angiopoietin-2 (Ang-2)

Extra luminal scaffold

Glycan-interacting compounds and methods of use

MSLN targeting trispecific proteins and methods of use

SELECTIVE IMMUNODEPLETION OF ENDOGENOUS STEM CELL NICHE FOR ENGRAFTMENT

BINDING MEMBERS OF INTERLEUKIN-4 RECEPTOR ALPHA (IL4-Ra)

Tumor-specific anti-EGFR antibody and application thereof

Anti-MET antibodies and compositions

Anti CD84 antibodies, compositions comprising same and uses thereof

Combination therapy involving antibodies against Claudin 18.2 for treatment of cancer

Immunoconjugates

Antibody Fc mutants with ablated effector functions

Use of pentoxifylline with immune checkpoint-blockade therapies for the treatment of melanoma

Anti-nodal antibodies and methods of using same

ANTIBODY DRUG CONJUGATES OF KINESIN SPINDEL PROTEIN (KSP) INHIBITORS WITH ANTI-TWEAKR-ANTIBODIES

Antibody drug conjugates of kinesin spindel protein (KSP) inhibitors with anti-CD123-antibodies

Anti-BARF1 monoclonal antibody

Antibodies specific for IL-21 and uses thereof

Method for the treatment of malignancies

BIOMARKERS AND METHODS OF TREATING PD-1 AND PD-L1 RELATED CONDITIONS

Bispecific antibody-mediated cancer therapy with cytokine-induced killer cell

Antibodies against the MUC1-C/extracellular domain (MUC1-C/ECD)

Treatment of cancer using a CD123 chimeric antigen receptor

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

Humanized antigen-binding domains and methods of use

Anti-CD33 antibodies and immunoconjugates

Method For Making Heteromultimeric Molecules

Anti-age antibodies and methods of use thereof

ENHANCING ANTI-CANCER ACTIVITY OF IMMUNOMODULATORY FC FUSION PROTEINS

Combination therapy of immunotoxin and checkpoint inhibitor

Vaccines against antigens involved in therapy resistance and methods of using same

TREATMENT OF OCULAR NEOVASCULARIZATION USING ANTI-VEGF PROTEINS

HETERODIMERIC ANTIBODIES THAT BIND CD3 AND CD38

VEGF/DLL4 binding agents and uses thereof

Therapeutic antibodies and their uses

Combination therapy for the treatment of cancer

Monoclonal antibodies to growth and differentiation factor 15 (GDF-15), and uses thereof for treating cancer cachexia and cancer

Anti-nodal antibodies and methods of using same

Antibody drug conjugates (ADC) that bind to 191P4D12 proteins

Method of treatment of leukemia with anti-IL1RAP antibodies

Bispecific CD33 and CD3 binding proteins

KIR3DL2 IS A BIOMARKER AND A THERAPEUTIC TARGET USEFUL FOR RESPECTIVELY PREVENTING AND TREATING A SUBSET OF CUTANEOUS AND NON-CUTANEOUS PERIPHERAL T-CELL LYMPHOMAS

Methods of treatment using human anti-IL-23 antibodies

Anti-PD-L1-anti-TIM-3 bispecific antibodies

Determining WT-1 specific T cells and WT-1 specific T cell receptors (TCRs)

Heterodimeric antibodies that bind CD3 and tumor antigens

PRODUCTION OF HETEROMULTIMERIC PROTEINS

Bispecific antigen-binding constructs targeting Her2

CAR-EXPRESSING NK-92 CELLS AS CELL THERAPEUTIC AGENTS

MOLECULES WITH BIMODAL ACTIVITY DEPLETING TARGET AT LOW DOSE AND INCREASING IMMUNOSUPPRESSION AT HIGHER DOSE

Bispecific Constructs and Their Use in the Treatment of Various Diseases

PD-1 antibodies and uses thereof

ANTIBODIES AGAINST HUMAN ANGIOPOIETIN 2

TRIVALENT, BISPECIFIC ANTIBODIES

Claudin-18.2-specific immunoreceptors and T cell epitopes

Compositions and methods for treating cancer with anti-CD33 immunotherapy

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

Antibodies targeting quiescin sulfhydryl oxidase (QSOX1) and uses of same

Antigen-binding constructs targeting HER2

ANTI-CD40 ANTIBODIES AND METHODS OF USE

Antibody for immunoassay and method for preparing same

Bispecific HER2 and CD3 binding molecules

HUMANIZED ANTI-CD19 ANTIBODIES AND THEIR USE IN TREATMENT OF ONCOLOGY, TRANSPLANTATION AND AUTOIMMUNE DISEASE

Binding molecules specific for ASCT2 and uses thereof

Pharmaceutical compositions comprising humanized anti-CCR4 IgG4 antibody

Targeted immunotolerance

Method of treating cancer by administering multivalent fibronectin based scaffold domain proteins

Core constructs and their uses in configuring pharmaceutical molecules

Methods of using anti-phospholipase D4 antibodies

Humanized anti-TF-antigen antibodies

COMBINATION THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR TREATMENT OF CANCER

Bispecific EGFR/C-Met Antibodies

Treatment of pediatric brain tumors with targeting of CD47 pathway

CYTOTOXIC PROTEINS COMPRISING CELL-TARGETING BINDING REGIONS AND SHIGA TOXIN A SUBUNIT REGIONS FOR SELECTIVE KILLING OF SPECIFIC CELL TYPES

Chimeric antigen receptor to which anti-cotinine antibody is linked, and use thereof

Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers

H3T3A mutant protein efficiently reduces H3T3P and causes increased cell death of rapidly dividing cells

COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR

Antibody drug conjugates (ADC) that bind to 158P1D7 proteins

Methods for the Modulation of LGALS3BP to Treat Systemic Lupus Erythematosus

Compositions and methods for inducing phagocytosis of MHC class I positive cells and countering anti-CD47/SIRPA resistance

COMPOSITIONS AND METHODS FOR MODULATING IMMUNE RESPONSES

Combination immunotherapy for the treatment of cancer

Anti-PD1 antibodies and their use as therapeutics and diagnostics

Antibody therapeutics that bind TIM3

Mesothelin-targeted chimeric antigen receptors and methods of making them

Treating inflammation with IL-17/IL-23 bispecific antibodies

NOVEL ANTI-IL13 ANTIBODIES AND USES THEREOF

Peptides and combination of peptides for use in immunotherapy and methods for generating scaffolds for the use against pancreatic cancer and other cancers

Peptides and combination of peptides for use in immunotherapy and methods for generating scaffolds for the use against pancreatic cancer and other cancers

Compositions and methods for TCR reprogramming using fusion proteins

MULTIMERIZATION TECHNOLOGIES

Dual variable domain immunoconjugates and uses thereof

Bispecific antibody binding TRAIL-R2 and CD3

CD47 antibodies, methods, and uses

Antibody to human and mouse SEMA3A and use thereof

Cytotoxicity-inducing therapeutic agent

Fully human anti-mesothelin antibodies and immune effector cells targeting mesothelin

Antibodies against human CSF-1R and uses thereof

ANTI IL-3R ALPHA AGENTS AND USES THEREOF

Antibody to human and mouse Sema3A and use thereof

Antibody to human and mouse SEMA3A and use thereof

Polynucleotides encoding anti-CXCL13 antibodies

Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof

Compositions and methods for TCR reprogramming using fusion proteins

ANTIBODIES RECOGNIZING A CARBOHYDRATE CONTAINING EPITOPE ON CD-43 AND CEA EXPRESSED ON CANCER CELLS AND METHODS USING SAME

Recombinant human IgM-antibody effective against cancer cells

Antibody fragments, compositions and uses thereof

Human CD3 binding antibody

Anti-αβTCR antibody

Bivalent antibody directed against NKG2D and tumor associated antigens

NOVEL MODULATORS AND METHODS OF USE

Anti-CK8 antibodies for use in the treatment of colorectal cancers

Detection and treatment of malignant tumours in the CNS

Near infrared photoimmunotherapy (NIR-PIT) of suppressor cells to treat cancer

Methods and compositions for improving antiangiogenic therapy with anti-integrins

COMBINATION THERAPY FOR CANCER TREATMENT

Carrier-binding agent compositions and methods of making and using the same

Bispecific-Fc molecules

Antibody

Antibodies to endoplasmin and their use

Treatment of cancer using chimeric CD3 receptor proteins

Combinations and uses thereof

Materials and Methods for Eliciting Targeted Antibody Responses In Vivo

Nucleic acid sequencing using affinity reagents

Heterodimeric antibodies that bind CD3 and tumor antigens

MUC1* antibodies

COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING CANCER

CANCER METASTASIS INHIBITOR

Anti-CS1 antibodies and antibody drug conjugates

Compounds and methods for treating pain

Extension sequences for diabodies

NOVEL PROTEIN TRANSFECTION COMPOSITIONS AND USES THEREOF

USE OF ANTIBODIES AGAINST ICAM-1 IN COMBINATION WITH AN ANTI CANCER DRUG IN THE TREATMENT OF PATIENTS

Anti c-Met antibodies

Antibodies that bind colony stimulating factor 1 receptor (CSF1R)

METHODS AND COMPOSITIONS FOR INHIBITING CD32B EXPRESSING CELLS

METHODS AND COMPOSITIONS FOR INHIBITING CD32B EXPRESSING CELLS

Conjugates that are configured for targeted delivery of therapeutic compounds to senescent cells

COMBINATIONS OF EPIDERMAL GROWTH FACTOR RECEPTOR TARGETING ANTIBODIES FOR TREATING CANCER

USES OF MONOCLONAL ANTIBODY 8H9

Methods for enhancing anti-tumor antibody therapy

Cytotoxic and anti-mitotic compounds, and methods of using the same

Antibodies against human CSF-1R and uses thereof

Dual-target antibody targeting VEGFR-2 and DLL4 and pharmaceutical composition including same

RECOMBINANT ANTIBODY MOLECULE AND ITS USE FOR TARGET CELL RESTRICTED T CELL ACTIVATION

Antibodies targeting CDH19 for melanoma

VEGF-SPECIFIC ANTAGONISTS FOR ADJUVANT AND NEOADJUVANT THERAPY AND THE TREATMENT OF EARLY STAGE TUMORS

Method of modulating a chimeric antigen receptor t cell immune response by administering IL-10

Use of oncolytic herpes simplex virus, alone or in combination with immune check-point inhibitor, in the treatment of cancer

THERAPEUTIC AND DIAGNOSTIC TARGET FOR CANCER COMPRISING DLL3 BINDING REAGENTS

Anti-CD47 antibodies and methods of use

Isolated antibodies against interleukin-17 receptor B (IL-17RB) for cancer therapy

Modified vaccinia virus strains for use in diagnostic and therapeutic methods

Bispecific binding proteins that bind CD40 and mesothelin

Endoglin Antibodies

Antagonistic anti-tumor necrosis factor receptor 2 antibodies

Compositions and methods for treating cancer

Drug-conjugated bi-specific antigen-binding constructs

Antibodies targeting B-cell receptor complex membrane bound IgM and uses thereof

ANTI CD37 ANTIBODIES